Consensus Amedisys, Inc.

Equities

AMED

US0234361089

Delayed Nasdaq Other stock markets 03:58:54 2024-04-23 pm EDT			5-day change	1st Jan Change
91.2 ^USD	-0.04%		-0.03%	-4.04%

Mar. 25	UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says	MT
Mar. 25	Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says	MT

Evolution of the average Target Price on Amedisys, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a8c65b18d486fcfcbccbffaf9678.u19HkbXqhdi924srGkeeMH9XoF_OoIZNzY4O9Is-_ZQ.0DZ1x8Sd9O_K4-8cXRXUchQ0k2m07vEgpeNog_0OkKD-JwXL7djLr83tvw~3a7066d4c757d18cddea4c9180823211

Analyst Recommendations on Amedisys, Inc.

RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating	Mar. 25	MT
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating	23-09-14	MT
Deutsche Bank Adjusts Amedisys Price Target to $101 From $97, Maintains Buy Rating	23-07-31	MT
Jefferies Downgrades Amedisys to Hold From Buy, Adjusts Price Target to $101 From $98	23-07-06	MT
Benchmark Downgrades Amedisys to Hold From Buy	23-06-27	MT
Truist Securities Raises Amedisys Price Target to $101 From $97, Maintains Hold Rating	23-06-27	MT
Truist Securities Downgrades Amedisys to Hold From Buy, Price Target is $97	23-06-07	MT
Cantor Fitzgerald Adjusts Price Target on Amedisys to $100 From $91, Keeps Neutral Rating	23-06-06	MT
Credit Suisse Downgrades Amedisys to Neutral From Outperform Due to Competing Offers From Optum, Option Care; Trims PT to $100 From $115	23-06-06	MT
TD Cowen Adjusts Price Target on Amedisys to $84 From $95, Maintains Market Perform Rating	23-05-08	MT
Barclays Adjusts Price Target on Amedisys to $88 From $93, Maintains Equalweight Rating	23-05-05	MT
Truist Securities Adjusts Price Target on Amedisys to $97 From $115, Maintains Buy Rating	23-05-04	MT
UBS Adjusts Amedisys Price Target to $73 From $72, Maintains Sell Rating	23-05-04	MT
Stocks Slip Pre-Bell Following Latest Fed Rate Hike; Asia Mixed, Europe Down	23-05-04	MT
Cantor Fitzgerald Initiates Amedisys at Neutral With $87 Price Target	23-04-21	MT
UBS Adjusts Amedisys Price Target to $72 From $88, Maintains Sell Rating	23-04-17	MT
Truist Securities Adjusts Price Target on Amedisys to $115 From $130, Maintains Buy Rating	23-04-13	MT
Barclays Starts Amedisys at Equalweight With $93 Price Target	23-03-13	MT
RBC Adjusts Price Target on Amedisys to $111 From $114, Maintains Outperform Rating	23-02-21	MT
Benchmark Cuts Amedisys' Price Target to $115 From $120, Maintains Buy Rating	23-02-16	MT
Benchmark Company Adjusts Amedisys Price Target to $120 From $135, Maintains Buy Rating	23-01-25	MT
RBC Cuts PT on Amedisys to $114 From $139 Amid 'More Conservative' View, Increased Labor Investments; Outperform Kept	23-01-24	MT
Credit Suisse Lowers Amedisys' PT to $115 From $140, Lowers 2023 EBITDA Estimates Due to More Cautious View on Growth; Keeps Outperform Rating	23-01-23	MT
Oppenheimer Adjusts Amedisys Price Target to $125 From $145, Maintains Outperform Rating	23-01-19	MT
SVB Securities Adjusts Price Target on Amedisys to $85 From $96, Maintains Market Perform Rating	23-01-05	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

91.24 USD

Average target price

97.78 USD

Spread / Average Target

+7.17%

High Price Target

101 USD

Spread / Highest target

+10.70%

Low Price Target

73 USD

Spread / Lowest Target

-19.99%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Amedisys, Inc.

RBC Capital Markets
Cantor Fitzgerald
Deutsche Bank Securities
Jefferies & Co.
Benchmark Company
Truist Securities
Credit Suisse
TD Cowen
Barclays
UBS
Oppenheimer
SVB Securities LLC
Stephens Inc.
Raymond James
Benchmark Capital
Stifel Nicolaus
BofA Securities
SVB Leerink
BMO Capital
Cowen

Ratings for Amedisys, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar